Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics approval. The study is being conducted in connection with the development of iSTRYM, the firms digital therapeutics platform.

The ethics approval, which comes from Veritas IRB, effectively ensures that processes included in research studies respects participants rights and that they are delivered utilizing the highest standards of ethical practice in human studies. The approval effectively signifies the scientific validation of the study.

The study is being conducted to inform the development of iSTRYM, and how it is built out to best serve therapists, patients, and the psychedelics industry as a whole.

“As we build out iSTRYM to be the largest data repository of psychedelic experiences, we are ensuring that its development is rooted in research proof and a deep understanding of the systems and protocols provided during psychedelic therapy.”

Kelsey Ramsden, CEO of Mind Cure Health

Mind Cure Health last traded at $0.55 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Gold’s Wild Bull Run: Are Markets About to Break? | Mike McGlone

First Majestic Silver: The Santa Elena Mine

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

Mindcure Completes Beta Testing, Launches PsyCollage

Mind Cure Health (CSE: MCUR) has completed the beta testing phase for its proprietary bioinformatics...

Tuesday, February 16, 2021, 07:22:53 AM

Mind Cure Health Begins Research Into Psychedelic Compounds

Mind Cure Health (CSE: MCUR) has reached a milestone, with the company this morning announcing...

Tuesday, December 8, 2020, 08:04:33 AM

Mind Cure Health Announces $3.0 Million Financing

Mind Cure Health (CSE: MCUR) this morning announced that it is conducting a non-brokered private...

Friday, November 13, 2020, 08:28:28 AM

Mind Cure Receives Health Canada Approval For Sale Of Moonbeam Mushroom Products

Mind Cure Health (CSE: MCUR) has received the required authorizations from Health Canada for its...

Wednesday, September 23, 2020, 08:33:06 AM

Mind Cure Announces New Product, Launch Dates For Nootropic Products

Mind Cure Health (CSE: MCUR) this morning announced that it intends to bring a new...

Tuesday, December 29, 2020, 07:14:06 AM